MB-CART20.1
- Generic Name
- MB-CART20.1
MB-CART20.1 Lymphoma
Phase 1
Completed
- Conditions
- B-cell Lymphoma RecurrentNon-Hodgkin's LymphomaRelapsed or Refractory B-cell Non-Hodgkin's LymphomaB-cell Lymphoma Refractory
- Interventions
- First Posted Date
- 2018-09-10
- Last Posted Date
- 2024-11-21
- Lead Sponsor
- Miltenyi Biomedicine GmbH
- Target Recruit Count
- 10
- Registration Number
- NCT03664635
- Locations
- 🇩🇪
Universitätsklikum Leipzig, AöR, Leipzig, Germany
🇩🇪University Hospital of Cologne - Clinic for Internal Medicine I, Cologne, Germany
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath